Allergic asthma
MONDO:0004784A asthma with a basis in a pathological type I hypersensitivity reaction.
Also known as: allergic form of asthma
47 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Needle-Free epinephrine film could transform emergency allergy care for kids
Disease control CompletedThis study tests a new dissolving film called DESF that delivers epinephrine under the tongue. It is designed for children ages 7 to 17 who weigh at least 30 kg and have a history of allergic reactions that put them at high risk for severe episodes like anaphylaxis. The goal is t…
Phase: PHASE1 • Sponsor: Aquestive Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Allergy shots may unlock better asthma control by targeting hidden immune signals
Disease control CompletedThis study looks at how allergy shots (subcutaneous allergen immunotherapy) affect immune markers in adults with allergic asthma. Researchers will measure changes in eosinophil cationic protein and sputum eosinophils over six months, along with asthma symptom scores. The goal is …
Phase: NA • Sponsor: Mansoura University Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Skin test may personalize asthma care for kids
Disease control CompletedThis study tests whether a skin test that measures histamine response can help doctors decide if adding an antihistamine (Levocetirizine) to standard asthma treatment improves control in children aged 6-17 with allergic asthma. About 300 African American/Black and Caucasian/White…
Phase: PHASE3 • Sponsor: Bridgette Jones • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New asthma drug JYB1904 shows promise in early trial
Disease control CompletedThis study tested a new drug, JYB1904, in 69 adults with allergic asthma. Participants received either JYB1904 every 8 weeks or the standard drug omalizumab every 2 to 4 weeks for 24 weeks. The goal was to see how the drug behaves in the body, how safe it is, and how well it cont…
Phase: PHASE2 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New antibody drug shows promise for blocking asthma attacks
Disease control CompletedThis phase II trial tested a drug called huMAb OX40L in 29 adults with mild allergic asthma. The drug is an antibody designed to block a protein that triggers allergic reactions in the airways. Researchers measured whether it could prevent breathing problems caused by allergens, …
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Real-world study confirms mepolizumab cuts asthma attacks and steroid use
Disease control CompletedThis study followed 106 adults with severe eosinophilic asthma in Poland who received mepolizumab injections every 4 weeks for at least a year. Researchers tracked asthma attacks and the need for oral steroids before and during treatment. The goal was to see if the drug helps con…
Sponsor: Medical University of Lodz • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Asthma and obesity study probes Dupilumab's cellular effects
Knowledge-focused CompletedThis study looked at how the drug dupilumab changes gene and protein activity in airway cells from adults with asthma and obesity. Researchers compared allergic and non-allergic participants to understand different treatment responses. The goal was to gather knowledge, not to tes…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Grass allergy test study seeks better standardization
Knowledge-focused CompletedThis study aimed to find the right strength of two grass allergen extracts (timothy and orchard grass) to cause a skin reaction similar to histamine. Thirty-one adults with grass pollen allergies received skin prick tests with different concentrations. The goal was to improve all…
Phase: NA • Sponsor: Inmunotek S.L. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC